GoHealth, Inc.
NASDAQ:GOCO
9.435 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 734.671 | 631.675 | 1,062.415 | 877.35 | 539.501 | 226.205 |
| Cost of Revenue
| 264.709 | 187.67 | 239.335 | 199.202 | 202.538 | 79.582 |
| Gross Profit
| 469.962 | 444.005 | 823.08 | 678.148 | 336.963 | 146.623 |
| Gross Profit Ratio
| 0.64 | 0.703 | 0.775 | 0.773 | 0.625 | 0.648 |
| Reseach & Development Expenses
| -0 | -0 | -0 | -0 | -0 | 16.197 |
| General & Administrative Expenses
| 93.069 | 116.53 | 98.183 | 197.229 | 182.618 | 27.458 |
| Selling & Marketing Expenses
| 205.042 | 207.559 | 365.141 | 206.864 | 0 | 28.129 |
| SG&A
| 298.111 | 324.089 | 463.324 | 404.093 | -0 | 55.587 |
| Other Expenses
| -537.036 | 401.053 | 462.65 | 318.901 | -87.525 | -0.379 |
| Operating Expenses
| 537.036 | 725.142 | 925.974 | 722.994 | 290.528 | 117.86 |
| Operating Income
| -67.074 | -281.137 | -102.225 | -44.488 | 46.435 | 28.763 |
| Operating Income Ratio
| -0.091 | -0.445 | -0.096 | -0.051 | 0.086 | 0.127 |
| Total Other Income Expenses Net
| -84.042 | -94.483 | -431.993 | -52.669 | -87.525 | -0.379 |
| Income Before Tax
| -151.116 | -375.62 | -534.218 | -97.157 | -41.09 | 28.16 |
| Income Before Tax Ratio
| -0.206 | -0.595 | -0.503 | -0.111 | -0.076 | 0.124 |
| Income Tax Expense
| 0.154 | 0.764 | -0.024 | 0.043 | -0.022 | 0.046 |
| Net Income
| -63.257 | -376.384 | -534.194 | -97.2 | -41.068 | 28.117 |
| Net Income Ratio
| -0.086 | -0.596 | -0.503 | -0.111 | -0.076 | 0.124 |
| EPS
| -6.81 | -44.57 | -75.6 | -17.32 | -7.32 | 1.34 |
| EPS Diluted
| -6.81 | -44.57 | -75.6 | -17.32 | -7.32 | 1.34 |
| EBITDA
| 38.674 | -174.02 | 5.282 | 54.064 | 79.42 | 34.544 |
| EBITDA Ratio
| 0.053 | -0.275 | 0.005 | 0.062 | 0.147 | 0.153 |